42 related articles for article (PubMed ID: 15842464)
1. Oral drugs in the treatment of metastatic colorectal cancer.
García-Alfonso P; Muñoz Martín AJ; Ortega Morán L; Soto Alsar J; Torres Pérez-Solero G; Blanco Codesido M; Calvo Ferrandiz PA; Grasso Cicala S
Ther Adv Med Oncol; 2021; 13():17588359211009001. PubMed ID: 33995592
[TBL] [Abstract][Full Text] [Related]
2. Patient Preferences Associated with Therapies for Psoriatic Arthritis: A Conjoint Analysis.
Xu Y; Sudharshan L; Hsu MA; Koenig AS; Cappelleri JC; Liu WF; Smith TW; Pasquale MK
Am Health Drug Benefits; 2018 Nov; 11(8):408-417. PubMed ID: 30647828
[TBL] [Abstract][Full Text] [Related]
3. Oral versus intravenous fluoropyrimidines for colorectal cancer.
Chionh F; Lau D; Yeung Y; Price T; Tebbutt N
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD008398. PubMed ID: 28752564
[TBL] [Abstract][Full Text] [Related]
4. Factors Impacting Treatment Choice in the First-Line Treatment of Colorectal Cancer.
Bloem LT; De Abreu Lourenço R; Chin M; Ly B; Haas M
Oncol Ther; 2016; 4(1):103-116. PubMed ID: 28261643
[TBL] [Abstract][Full Text] [Related]
5. Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement.
Stuurman FE; Nuijen B; Beijnen JH; Schellens JH
Clin Pharmacokinet; 2013 Jun; 52(6):399-414. PubMed ID: 23420518
[TBL] [Abstract][Full Text] [Related]
6. Tegafur-uracil is a safe alternative for the treatment of colorectal cancer in patients with partial dihydropyrimidine dehydrogenase deficiency: a proof of principle.
Cubero DI; Cruz FM; Santi P; Silva ID; Del Giglio A
Ther Adv Med Oncol; 2012 Jul; 4(4):167-72. PubMed ID: 22754590
[TBL] [Abstract][Full Text] [Related]
7. Acceptance of oral chemotherapy in breast cancer patients - a survey study.
Schott S; Schneeweiss A; Reinhardt J; Bruckner T; Domschke C; Sohn C; Eichbaum MH
BMC Cancer; 2011 Apr; 11():129. PubMed ID: 21486437
[TBL] [Abstract][Full Text] [Related]
8. Alternating irinotecan with oxaliplatin combined with UFT plus leucovorin (SCOUT) in metastatic colorectal cancer.
Sheikh HY; Valle JW; Waddell T; Palmer K; Wilson G; Sjursen A; Craven O; Swindell R; Saunders MP
Br J Cancer; 2008 Aug; 99(4):577-83. PubMed ID: 18682717
[TBL] [Abstract][Full Text] [Related]
9. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
Hoff PM; Pazdur R; Benner SE; Canetta R
Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
[TBL] [Abstract][Full Text] [Related]
10. The role of UFT in metastatic colorectal cancer.
Bennouna J; Saunders M; Douillard JY
Oncology; 2009; 76(5):301-10. PubMed ID: 19299903
[TBL] [Abstract][Full Text] [Related]
11. Randomized crossover trial of intravenous 5-FU versus oral UFT both modulated by leucovorin: a one-centre experience.
Lima AP; del Giglio A
Eur J Cancer Care (Engl); 2005 May; 14(2):151-4. PubMed ID: 15842464
[TBL] [Abstract][Full Text] [Related]
12. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.
Lembersky BC; Wieand HS; Petrelli NJ; O'Connell MJ; Colangelo LH; Smith RE; Seay TE; Giguere JK; Marshall ME; Jacobs AD; Colman LK; Soran A; Yothers G; Wolmark N
J Clin Oncol; 2006 May; 24(13):2059-64. PubMed ID: 16648506
[TBL] [Abstract][Full Text] [Related]
13. Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer.
Borner MM; Schoffski P; de Wit R; Caponigro F; Comella G; Sulkes A; Greim G; Peters GJ; van der Born K; Wanders J; de Boer RF; Martin C; Fumoleau P
Eur J Cancer; 2002 Feb; 38(3):349-58. PubMed ID: 11818199
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
Shirao K; Hoff PM; Ohtsu A; Loehrer PJ; Hyodo I; Wadler S; Wadleigh RG; O'Dwyer PJ; Muro K; Yamada Y; Boku N; Nagashima F; Abbruzzese JL
J Clin Oncol; 2004 Sep; 22(17):3466-74. PubMed ID: 15277535
[TBL] [Abstract][Full Text] [Related]
15. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
